Rufinamide Suspension
Product Images NDC 59651-563

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 59651-563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Rufinamide Fig 1)

An instructional illustration showing components for administering Rufinamide suspension 40 mg/mL by Aurobindo Pharma Limited. The drawing depicts a bottle of suspension, a box, a bottle adapter, and two syringes for dosing measurement and delivery.*

FDA Label Image

Fig10 (Rufinamide Fig 10)

An instructional illustration showing a hand drawing a liquid medication from a cup into a syringe on the left side, and the right side depicts a hand pressing the syringe plunger to dispense liquid drops from the syringe tip. This diagram likely demonstrates how to measure and administer RUFINAMIDE oral suspension using a syringe.*

FDA Label Image

Fig11 (Rufinamide Fig 11)

An instructional line drawing showing a hand grasping the cap of a bottle, illustrating how to open or handle the cap of a liquid medication container, relevant for oral suspension products.*

FDA Label Image

Figure 12 (Rufinamide Fig 12)

Label for Rufinamide Oral Suspension 40 mg/mL, an oral prescription drug by Aurobindo Pharma Limited. The label includes administration instructions, storage conditions, and distribution details by Aurobindo Pharma USA, Inc. The bottle volume is 460 mL. It also features a barcode and a note to dispense a Medication Guide with each dispensing.*

FDA Label Image

Figure 13 (Rufinamide Fig 13)

Label for Rufinamide Oral Suspension 40 mg/mL by Aurobindo Pharma Limited. The label provides instructions including a caution to dispense the medication guide separately and notes the product is supplied with two 20 mL syringes. The suspension is for oral administration only, with storage instructions and a 90-day discard period after opening. The label includes the NDC 59651-563-60 and distributor address in East Windsor, NJ.*

FDA Label Image

Fig2 (Rufinamide Fig 2)

An illustration showing a hand holding a bottle of Rufinamide oral suspension (40 mg/mL), with an arrow indicating to shake the bottle well before use.*

FDA Label Image

Fig3 (Rufinamide Fig 3)

An instructional illustration showing a bottle adapter, depicted as a short cylindrical component with multiple horizontal sections. It is labeled clearly to indicate its function as a bottle adapter.*

FDA Label Image

Fig4 (Rufinamide Fig 4)

An instructional illustration showing a hand gripping the neck of a bottle with a cap removed and a downward arrow indicating that the cap should be pressed or screwed on the bottle. This likely relates to the proper closure of the bottle containing Rufinamide oral suspension.*

FDA Label Image

Fig5 (Rufinamide Fig 5)

An illustration of an oral dosing syringe for Rufinamide suspension 40 mg/mL. The syringe has clear volume markings up to 20 mL and is labeled with a plunger at the bottom, indicating its use for measuring and administering the medication orally.*

FDA Label Image

Fig6 (Rufinamide Fig 6)

An instructional illustration showing a hand holding a syringe above an open bottle, with an arrow pointing downward, suggesting how to withdraw liquid medication from the bottle using the syringe.*

FDA Label Image

Fig7 (Rufinamide Fig 7)

An instructional illustration showing a hand holding a syringe filled with liquid, with the plunger being pushed down by another finger, accompanied by a downward-pointing arrow indicating the direction for administration or dispensing.*

FDA Label Image

Fig8 (Rufinamide Fig 8)

An instructional diagram showing a hand holding a syringe. The plunger is being measured, with an annotation indicating to measure to the white end of the plunger. The syringe is marked with volume measurements from 1 mL to 10 mL.*

FDA Label Image

Fig9 (Rufinamide Fig 9)

Black and white line drawing illustrating oral administration of medication using a syringe. The image shows a person holding a dosing syringe near their mouth to receive the oral suspension. This depicts how to measure and give the liquid medication.*

FDA Label Image

Structure (Rufinamide Str)

Chemical structure of Rufinamide, showing a triazole ring attached to a substituted benzene ring with two fluorine atoms and a carboxamide group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.